Literature DB >> 6299753

Biological activity of anti-thyrotropin anti-idiotypic antibody.

M N Islam, B M Pepper, R Briones-Urbina, N R Farid.   

Abstract

Rabbit anti-rat anti-human thyrotropin anti-idiotypic antibodies have been raised. These antibodies were active at the thyrotropin (TSH) receptor, in that they inhibited 125I-labeled bovine TSH binding to thyroid plasma membranes, stimulated adenylate cyclase activity through a guanyl nucleotide-dependent mechanism, augmented radioiodide transport into isolated porcine thyroid follicular cells and induced such cultured cells to organize into follicles. Aside from substantiating the expectation that anti-hormone anti-idiotypic antibodies may possess properties of the original hormone, this work raised the possibility that thyroid-stimulating antibodies which cause the hyperthyroidism of Graves' disease may be anti-TSH anti-idiotypic antibodies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299753     DOI: 10.1002/eji.1830130113

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Cleavage of the thyrotropin receptor.

Authors:  N M Islam; C L Hew; V Kaczur; N R Farid
Journal:  J Endocrinol Invest       Date:  2001-11       Impact factor: 4.256

2.  Anti-bovine thyrotropin autoantibodies in patients with Hashimoto's thyroiditis, subacute thyroiditis, and systemic lupus erythematosus.

Authors:  S Sakata; H Takuno; K Nagai; Y Kimata; H Maekawa; M Yamamoto; N Takeda; Y Ochi; K Miura
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 3.  The thyrotropin receptor and its role in Graves' disease.

Authors:  B Rees Smith; C R Rickards; E Davies Jones; Y Kajita; P R Buckland; F M Creagh; R D Howells; F Hashim; A B Parkes; V B Petersen
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

4.  Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.

Authors:  T Akamizu; T Mori; H Imura; J Noh; N Hamada; K Ito; Y Koizumi; T Yamada; T Fujihira; S Eto
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

5.  Anti-idiotypic antibodies that protect cells against the action of diphtheria toxin.

Authors:  J M Rolf; H M Gaudin; S M Tirrell; A B MacDonald; L Eidels
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.

Authors:  R Hörmann; B Saller; R Müller; K Mann
Journal:  Klin Wochenschr       Date:  1985-12-16

7.  Rabbits immunized with thyroid-stimulating hormone produce autoantiidiotypic thyroid-stimulating antibodies.

Authors:  G N Beall; B Rapoport; I J Chopra; S R Kruger
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

8.  Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.

Authors:  J R Baker; Y G Lukes; K D Burman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Hypothyroidism associated with anti-human chorionic gonadotropin antibodies secondarily produced by gonadotropin therapy in a case of idiopathic hypothalamic hypogonadism.

Authors:  T Ogura; Y Mimura; F Otsuka; M Kishida; K Yokota; J Suzuki; A Nagai; S Hirakawa; H Makino; K Tobe
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

10.  Effect of carbimazole treatment on specific and non-specific immunological parameters in patients with Graves' disease.

Authors:  J Charreire; G Karsenty; P Bouchard; G Schaison
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.